North American Drug Delivery Technologies Market Size by Type, By Distribution Channel, And Forecast till 2022-2031

Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.

The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017. Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.

The drug delivery technologies that have recently gained importance in the North American market include orodispersible tablet (ODT), dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets; controlled release is the most widely accepted technology. The use of implantable devices for drug delivery is also on a rise.

Big pharmaceutical companies such as Pfizer and Merck have established in-house capabilities for the development of drug delivery technologies. On the contrary, many other companies are still relying on specialty companies engaged in the development of drug delivery technologies. High level of competition and increasing need for outsourcing has resulted in the drug delivery market to be fragmented, with several small companies developing novel drug delivery technologies for niche therapeutic applications.

Access Free PDF With Graphs and Charts :

The North American drug delivery market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry , healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and rising number of drug delivery formulations and devices are propelling the Canadian market.

Key players in the drug delivery technologies market are 3M Company (U.S.), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton, Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.) and Valeant Pharmaceuticals (Canada).

Scope of the Report

This research report categorizes and analyzes the North American Drug Delivery Technologies market on the basis of routes of administration. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S and Canada), to provide in-depth information on the North American market scenario.

Request Sample For More Insights :

North American drug delivery technologies market, by segment:

Oral Drug Delivery
Controlled Release
Orodispersible Tablets (ODT) and Taste Masking
Pulmonary Drug Delivery
Dry Powder Inhalers
Metered Dose Inhalers
Transdermal Drug Delivery
Passive Drug Delivery
Reservoir System
Matrix System
Active Drug Delivery
Injectable Drug Delivery
Conventional Injection Devices
Fillable Syringes
Prefilled Syringes
Self-injection Devices
Needle-free Injectors
Auto-injectors or Safety Syringe Devices
Pen Injectors
Ocular Drug Delivery
Eye Drops
Ointment and Gel
Nasal Drug Delivery
Nasal Drops
Nasal Sprays
Nasal Inhalers
Topical Drug Delivery
Liquid Formulations
Semisolid Formulations
Solid Formulations
Implantable Drug Delivery
Drug-Eluting Stents
Implantable Infusion Pumps
Contraceptive Implants
Intravitreal Implants
Brachytherapy Seeds
Transmucosal Drug Delivery
Oral (Buccal and Sublingual)
Others (Rectal and Vaginal)

Related Reports:-

North American Drug Delivery Technologies Market
European Home Healthcare Market
Radiation Detection, Monitoring & Safety Market
European Injectable Drug Delivery Market
Aptamers Market
Next Generation Sequencing (NGS) Market
European Drug Delivery Technologies Market
Bioinformatics Market
North American Healthcare IT Market
Lab Automation Market

Leave a Reply

Your email address will not be published.